Press Releases

High Flow Nasal Cannula Market Size to Gain US$ 15,926.4 Million by 2030

According to Precedence Research’s new research study on “High Flow Nasal Cannula Market Size 2021 to 2030 – Global Industry Analysis and Forecast (By Product Type: Single heated tube, Nasal cannula, Active humidifier, and Air blender; By Application: Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease, Acute Heart Failure, and Others; By End-user: Hospitals and clinics, Ambulatory care centers, Long-term care centers, Others; By Sales Channel: Direct Channel and Distribution Channel)” The global high flow nasal cannula market size is forecasted to reach around US$ 15,926.4 million by 2030 and is anticipated to grow with a healthy CAGR of 11.3% from 2021 to 2030.

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1254

Crucial Factors Accountable for Market Growth Are:

  • Growing incidences of asthma and COPD across the globe
  • Low cost of high-flow nasal cannula compared to low-flow oxygen delivery systems
  • Growing geriatric population
  • Launch of advanced products by key operating players in the target industry

 Market Scope:

Report Highlights Details
Market Size USD 15,926.4 Billion by 2030
Growth Rate CAGR of 11.3% from 2021 to 2030
Base Year 2020
Forecast Period 2021 to 2030
Historic Data 2017 to 2020
Segments Covered Product, Application, End-User, Sales Channel, Region

Market Dynamics:

Precedence Research achieved with the global high-flow nasal cannula market is resulting in high adoptions by the government driving high growths for this market, whereas reasons such as the complex architectural model of the global high-flow nasal cannula market act as deterrents to the growth of this market. Availability of more economical integration services will bring more opportunities to the market. The report aims to provide an overview of the market with detailed market segmentation by integration type, deployment model, product type, application, end-user, sales channel, and geography. The global high-flow nasal cannula market is expected to witness rapid growth during the forecast period.

Demand for Diverse Oxygen Supply Technologies

The high flow rates demonstrated by nasal cannulas have allowed the medical sector to assess the efficacy of these devices. Also, the demand for oxygen supply in geriatric patients has furthermore opened up new paths for the market’s maturity and growth.

The healthcare sector has, frequently, pointed out the significance of respiratory support methods. Apart from this, the awareness of the masses about respiratory care has further created new prospects for advancement and growth, according to the Precedence Research’s study.

Some of the prominent players in the global High Flow Nasal Cannula Market are listed as below:

  • Armstrong Medical Ltd
  • Salter Labs Inc
  • ResMed, Inc.
  • Teleflex Inc
  • Vapotherm Inc.
  • Becton Dickinson, and Company
  • Smiths Medical
  • Flexicare Medical Ltd
  • Teijin Pharma Limited
  • TNI Medical AG
  • Fisher & Paykel Healthcare Limited
  • Hamilton Medical AG

In order to better recognize the current status of high flow nasal cannula, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the high flow nasal cannula market. Research study offers key insights on high flow nasal cannula market and research analysis of market size and trend for probable global market segments.

Key Market Developments:

  • In May 2017, Fisher & Paykel Healthcare Corporation Ltd.launchednew infant cannula range F&P Optiflow Junior 2 used for nasal high flow therapy.
  • In October 2016, Fisher & Paykel Healthcare announced new research on the benefits of its Optiflow nasal high flow therapy.

Major Market Segments Covered:

By Product Type

  • Single heated tube
  • Nasal cannula
  • Active humidifier
  • Air blender

By Application

  • Acute Respiratory Failure
  • Chronic Obstructive Pulmonary Disease
  • Acute Heart Failure
  • Others

By End-user

  • Hospitals and clinics
  • Ambulatory care centers
  • Long-term care centers
  • Others

By Sales Channel

  • Direct Channel
  • Distribution Channel

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENT

Chapter 1.    Introduction

1.1.    Research Objective
1.2.    Scope of the Study
1.3.    Definition

Chapter 2.    Research Methodology

2.1.    Research Approach
2.2.    Data Product Types
2.3.    Assumptions& Limitations

Chapter 3.    Executive Summary

3.1.    Market Snapshot

Chapter 4.    High Flow Nasal Cannula Market Variables and Scope 

4.1.    Introduction
4.2.    Market Classification and Scope

Chapter 5.    COVID 19 Impact on High Flow Nasal Cannula Market

5.1.    Covid-19: High Flow Nasal Cannula Industry Impact
5.2.    High Flow Nasal Cannula Business Impact Assessment: Covid-19
5.2.1.    Services Challenges/Disruption
5.2.2.    Market Trends and High Flow Nasal Cannula Opportunities in the COVID-19 Landscape for Major Markets
5.3.    Strategic Measures against Covid-19
5.3.1.    Government Support and Initiative to Combat Covid-19
5.3.2.    Proposal for High Flow Nasal Cannula Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6.    High Flow Nasal Cannula Market Dynamics Analysis and Trends

6.1.    Market Dynamics
6.1.1.    Market Drivers
6.1.1.1.    Ever-increasing number of respiratory disorders
6.1.1.2.    Low cost of high-flow nasal cannula compared to low-flow oxygen delivery systems
6.1.2.    Market Restraints
6.1.2.1.    Low rate of adoption of modern healthcare applications in developing countries
6.1.3.    Market Opportunities
6.1.3.1.    Increasing popularity and uptake of heated humidified high-flow nasal cannulas

Chapter 7.    Global High Flow Nasal Cannula Market: Competitive Landscape

7.1.1.    Company Market Share/Positioning Analysis
7.1.1.1.    High Flow Nasal Cannula Market Revenue by Market Players (2017 – 2020)
7.1.1.2.    High Flow Nasal Cannula Market Revenue Market Share by Market Players (2017 – 2020)
7.1.2.    Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1.    Product Portfolio, Expansion, Geographic Expansion, Product Innovation
7.1.2.2.    Merger and Acquisition, Collaboration and Partnerships
7.1.3.    Market Players Landscape
7.1.3.1.    List of Suppliers
7.1.3.2.    List of End user

Chapter 8.    Global High Flow Nasal Cannula Market, By Product Type

8.1.    High Flow Nasal Cannula Market, by Product Type, 2017-2030
8.1.1.    Single Heated Tube
8.1.1.1.    Market Revenue and Forecast (2017-2030)
8.1.2.    Nasal cannula
8.1.2.1.    Market Revenue and Forecast (2017-2030)
8.1.3.    Active humidifier
8.1.3.1.    Market Revenue and Forecast (2017-2030)
8.1.4.    Air blender
8.1.4.1.    Market Revenue and Forecast (2017-2030)

Chapter 9.    Global High Flow Nasal Cannula Market, By End-user

9.1.    High Flow Nasal Cannula Market, by End-user, 2017-2030
9.1.1.    Hospitals and clinics
9.1.1.1.    Market Revenue and Forecast (2017-2030)
9.1.2.    Ambulatory care centers
9.1.2.1.    Market Revenue and Forecast (2017-2030)
9.1.3.    Long-term care centers
9.1.3.1.    Market Revenue and Forecast (2017-2030)
9.1.4.    Others
9.1.4.1.    Market Revenue and Forecast (2017-2030)

Chapter 10.    Global High Flow Nasal Cannula Market, By Application

10.1.    High Flow Nasal Cannula Market, by Application, 2017-2030
10.1.1.    Acute Respiratory Disorder
10.1.1.1.    Market Revenue and Forecast (2017-2030)
10.1.2.    Chronic Respiratory Disorder
10.1.2.1.    Market Revenue and Forecast (2017-2030)
10.1.3.    Acute Heart Failures
10.1.3.1.    Market Revenue and Forecast (2017-2030)
10.1.4.    Others
10.1.4.1.    Market Revenue and Forecast (2017-2030)

Chapter 11.    Global High Flow Nasal Cannula Market, By Sales Channel 

11.1.    High Flow Nasal Cannula Market, by Sales Channel, 2017-2030
11.1.1.    Direct Channel
11.1.1.1.    Market Revenue and Forecast (2017-2030)
11.1.2.    Distribution Channel
11.1.2.1.    Market Revenue and Forecast (2017-2030)

Chapter 12.    Global High Flow Nasal Cannula Market, Regional Estimates and Trend Forecast

12.1.    North America
12.1.1.    Market Revenue Forecast by Product Type(2017-2030)
12.1.2.    Market Revenue Forecast by End-user (2017-2030)
12.1.3.    Market Revenue Forecast by Application (2017-2030)
12.1.4.    Market Revenue Forecast by Sales Channel (2017-2030)
12.1.5.    U.S
12.1.5.1.    Market Revenue Forecast (2017-2030)
12.1.6.    Canada
12.1.6.1.    Market Revenue Forecast (2017-2030)
12.2.    Europe
12.2.1.    Market Revenue Forecast by Product Type (2017-2030)
12.2.2.    Market Revenue Forecast by End-user (2017-2030)
12.2.3.    Market Revenue Forecast by Application (2017-2030)
12.2.4.    Market Revenue Forecast by Sales Channel (2017-2030)
12.2.5.    UK
12.2.5.1.    Market Revenue Forecast (2017-2030)
12.2.6.    Germany
12.2.6.1.    Market Revenue Forecast (2017-2030)
12.2.7.    France
12.2.7.1.    Market Revenue Forecast (2017-2030)
12.2.8.    Rest of EU
12.2.8.1.    Market Revenue Forecast (2017-2030)
12.3.    Asia Pacific (APAC)
12.3.1.    Market Revenue Forecast by Product Type (2017-2030)
12.3.2.    Market Revenue Forecast by End-user (2017-2030)
12.3.3.    Market Revenue Forecast by Application (2017-2030)
12.3.4.    Market Revenue Forecast by Sales Channel (2017-2030)
12.3.5.    China
12.3.5.1.    Market Revenue Forecast (2017-2030)
12.3.6.    India
12.3.6.1.    Market Revenue Forecast (2017-2030)
12.3.7.    Japan
12.3.7.1.    Market Revenue Forecast (2017-2030)
12.3.8.    Rest of APAC
12.3.8.1.    Market Revenue Forecast (2017-2030)
12.4.    LATAM
12.4.1.    Market Revenue Forecast by Product Type (2017-2030)
12.4.2.    Market Revenue Forecast by End-user (2017-2030)
12.4.3.    Market Revenue Forecast by Application (2017-2030)
12.4.4.    Market Revenue Forecast by Sales Channel (2017-2030)
12.4.5.    Brazil
12.4.5.1.    Market Revenue Forecast (2017-2030)
12.4.6.    Rest of LATAM
12.4.6.1.    Market Revenue Forecast (2017-2030)
12.5.    Middle East and Africa (MEA)
12.5.1.    Market Revenue Forecast by Product Type (2017-2030)
12.5.2.    Market Revenue Forecast by End-user (2017-2030)
12.5.3.    Market Revenue Forecast by Application (2017-2030)
12.5.4.    Market Revenue Forecast by Sales Channel (2017-2030)
12.5.5.    GCC
12.5.5.1.    Market Revenue Forecast (2017-2030)
12.5.6.    North Africa
12.5.6.1.    Market Revenue Forecast (2017-2030)
12.5.7.    South Africa
12.5.7.1.    Market Revenue Forecast (2017-2030)
12.5.8.    Rest of MEA
12.5.8.1.    Market Revenue Forecast (2017-2030)

Chapter 13.    Company Profiles

13.1.    Armstrong Medical Ltd
13.1.1.    Company Overview, Business Information, Regional Presence
13.1.2.    Product Portfolio, Analysis
13.1.2.1.    Product Details, Specification, Application
13.1.3.    Revenue, Price, and Gross Margin (2017-2020)
13.1.4.    Recent Developments and Strategies
13.2.    Becton Dickinson, and Company
13.2.1.    Company Overview, Business Information, Regional Presence
13.2.2.    Product Portfolio, Analysis
13.2.2.1.    Product Details, Specification, Application
13.2.3.    Revenue, Price, and Gross Margin (2017-2020)
13.2.4.    Recent Developments and Strategies
13.3.    Fisher & Paykel Healthcare Limited
13.3.1.    Company Overview, Business Information, Regional Presence
13.3.2.    Product Portfolio, Analysis
13.3.2.1.    Product Details, Specification, Application
13.3.3.    Revenue, Price, and Gross Margin (2017-2020)
13.3.4.    Recent Developments and Strategies
13.4.    Flexicare Medical Ltd
13.4.1.    Company Overview, Business Information, Regional Presence
13.4.2.    Product Portfolio, Analysis
13.4.2.1.    Product Details, Specification, Application
13.4.3.    Revenue, Price, and Gross Margin (2017-2020)
13.4.4.    Recent Developments and Strategies
13.5.    Hamilton Medical AG
13.5.1.    Company Overview, Business Information, Regional Presence
13.5.2.    Product Portfolio, Analysis
13.5.2.1.    Product Details, Specification, Application
13.5.3.    Revenue, Price, and Gross Margin (2017-2020)
13.5.4.    Recent Developments and Strategies
13.6.    ResMed, Inc.
13.6.1.    Company Overview, Business Information, Regional Presence
13.6.2.    Product Portfolio, Analysis
13.6.2.1.    Product Details, Specification, Application
13.6.3.    Revenue, Price, and Gross Margin (2017-2020)
13.6.4.    Recent Developments and Strategies
13.7.    Salter Labs Inc
13.7.1.    Company Overview, Business Information, Regional Presence
13.7.2.    Product Portfolio, Analysis
13.7.2.1.    Product Details, Specification, Application
13.7.3.    Revenue, Price, and Gross Margin (2017-2020)
13.7.4.    Recent Developments and Strategies
13.8.    Smiths Medical
13.8.1.    Company Overview, Business Information, Regional Presence
13.8.2.    Product Portfolio, Analysis
13.8.2.1.    Product Details, Specification, Application
13.8.3.    Revenue, Price, and Gross Margin (2017-2020)
13.8.4.    Recent Developments and Strategies
13.9.    Teijin Pharma Limited.
13.9.1.    Company Overview, Business Information, Regional Presence
13.9.2.    Product Portfolio, Analysis
13.9.2.1.    Product Details, Specification, Application
13.9.3.    Revenue, Price, and Gross Margin (2017-2020)
13.9.4.    Recent Developments and Strategies
13.10.    Teleflex Inc
13.10.1.    Company Overview, Business Information, Regional Presence
13.10.2.    Product Portfolio, Analysis
13.10.2.1.    Product Details, Specification, Application
13.10.3.    Revenue, Price, and Gross Margin (2017-2020)
13.10.4.    Recent Developments and Strategies
13.11.    TNI Medical AG
13.11.1.    Company Overview, Business Information, Regional Presence
13.11.2.    Product Portfolio, Analysis
13.11.2.1.    Product Details, Specification, Application
13.11.3.    Revenue, Price, and Gross Margin (2017-2020)
13.11.4.    Recent Developments and Strategies
13.12.    Vapotherm Inc.
13.12.1.    Company Overview, Business Information, Regional Presence
13.12.2.    Product Portfolio, Analysis
13.12.2.1.    Product Details, Specification, Application
13.12.3.    Revenue, Price, and Gross Margin (2017-2020)
13.12.4.    Recent Developments and Strategies

Chapter 14.    Appendix

14.1.    About Us
14.2.    Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1254

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Check Also
Close
Back to top button